Christopher Peer MS, MD
Board Certified Orthopedic Surgeon
Dr. Christopher Peer is affiliated with various medical societies and has received multiple awards for academic achievement. Additionally, he teaches surgery techniques and serves in leadership roles within orthopedic organizations. Dr. Peer is Board Certified in Orthopaedic Surgery with a Sub-Specialty Certificate in Orthopaedic Sports Medicine.
Areas of Specialty
- Knee and Shoulder Surgery
- Sports Medicine
- Knee and Shoulder Instability & Dislocations
- Joint Replacement
Professional Roles
- Chief Medical Officer KCOI
- Medical Director KCOI Ortho Urgent Care
- Associate Orthopaedic Sports Medicine Fellowship Director UMKC SOM
- Assistant Clinical Professor UMKC Dept of Orthopaedic Surgery
- American Academy of Orthopaedic Surgeons Course Faculty at Orthopaedic Learning Center
Education
- Fellowship: University of Missouri Kansas City/ KCOI
- Residency: University of New Mexico
- Doctor of Medicine: Georgetown University School of Medicine
Memberships
- ABOS Certification Orthopaedic Surgery
- ABOS Certification Orthopaedic Sports Medicine
- American Academy of Orthopedic Surgeons
- American Orthopaedic Society for Sports Medicine
- New England Shoulder and Elbow Society
Quote
“Thoughtful, experienced, individualized knee, shoulder, and sports expertise for athletes and other humans.”
More About Dr. Peer
Dr. Peer’s medical journey began as a patient when he tore his ACL while skiing for a college team in Vermont. Redirecting his career towards science and medicine, he earned Bachelor’s and Master’s degrees from Virginia Tech. Furthering his training at the National Institutes of Health, he was awarded a two-year research fellowship at the National Cancer Institute. He then moved to Dartmouth Medical School with Dr. Michael Sporn to continue cancer chemoprevention research.
Completing his medical education at Georgetown Medical School, where he served as class Vice President, Dr. Peer pursued surgical residency at the University of New Mexico. As Chief Resident on the Ortho Trauma service, he gained extensive experience. Following this, he worked as a fellow with the Sports Service at the Kansas City Orthopaedic Institute, also serving as assistant to the Head Team Physician for the Kansas City Chiefs.
Specializing in sports medicine and joint replacement, Dr. Peer consulted for the Kansas City Chiefs until 2015 and worked with ski patrol and college sports teams. Currently practicing in Kansas City, he focuses on sports medicine injuries, joint replacement, and complex knee and shoulder problems.
Dr. Peer is a huge believer in education. He prides himself on helping patients understand their conditions and outlining rational management strategies.
Dr. Peer's Publications
1. Ring-Shaped Lateral Meniscus Without a Bony Anterior Root Attachment. DB Luckenbill, CW Peer. 2021 Jan 1;44(1):e146-e147.
2. Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer. Suh N, Glasebrook AL, Palkowitz AD, Bryant HU, Burris LL, Starling JJ, Pearce HL, Williams C, Peer C, Wang Y, Sporn MB. Cancer Res. 2001 Dec 1;61(23):8412-5.
3. Retinoids increase cell-cell adhesion strength, beta-catenin protein stability, and localization to the cell membrane in a breast cancer cell line: a role for serine kinase activity. Byers S, Pishvaian M, Crockett C, Peer C, Tozeren A, Sporn M, Anzano M, Lechleider R. Endocrinology. 1996 Aug;137(8):3265-73.
4. Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid. Anzano MA, Peer CW, Smith JM, Mullen LT, Shrader MW, Logsdon DL, Driver CL, Brown CC, Roberts AB, Sporn MB. J Natl Cancer Inst. 1996 Jan 17;88(2):123-5.
5. The Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Lucia MS, Anzano MA, Slayter MV, Anver MR, Green DM, Shrader MW, Logsdon DL, Driver CL, Brown CC, Peer CW, et al. Cancer Res. 1995 Dec 1;55(23):5621-7.
6. Characterization of a CO: heterodisulfide oxidoreductase system from acetate-grown Methanosarcina thermophila. Peer CW, Painter MH, Rasche ME, Ferry JG. J Bacteriol. 1994 Nov;176(22):6974-9.
7. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB, Sporn MB. Cancer Res. 1994 Sep 1;54(17):4614-7.
8. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Anzano MA, Smith JM, Uskokovic MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader MW, Logsdon DL, Driver CL, et al. Cancer Res. 1994 Apr 1;54(7):1653-6.
PUBLISHED ABSTRACTS and PRESENTATIONS
9. LY353381.HCl, a new benzothiophene for chemoprevention of breast cancer. Sporn MB, Suh N, Peer C, Williams C, Roebuck B, Glasebrook A, et al. Proc Annu Meet Am Assoc Cancer Res. 38A3538, Mar 1997.
10. Prevention of experimental breast and prostate cancer with retinoids as single agents and in combination with related ligands. Sporn MB, Robert AB, Anzano M, Danielpour D, Lucia M, Peer C, Brown C. Proceedings, Fifth International Congress on Hormones and Cancer. Quebec. Aug 1995.
11. Vitamin D analogue synergizes with tamoxifen in prevention of mammary carcinogenesis. Anzano MA, Smith JM, Peer CW, Welsh M, Shrader M, Logsdon D, Driver C, Brown CC, Uskokovic M, Sporn MB. Gordon Conference. Jul 1995.
12. Vitamin D analogue synergizes with tamoxifen in prevention of mammary carcinogenesis. Anzano MA, Smith JM, Peer CW, Welsh M, Shrader M, Logsdon D, Driver C, Brown CC, Uskokovic M, Sporn MB. Proc Annu Meet Am Assoc Cancer Res. 35:623. Mar 1994.
13. Use, Safety and Outcome of Collagraft Triphasic Bone Substitue After Resection of Pediatric Benign Bone Tumors. C. Peer, RS Scwhend, E Benson. Carrie Tingley Winter Conference. Jan 2005. Albuquerque, NM.
14. Approach to Management of Acute Hand Injuries and Infections. C. Peer, MD. 25th Annual American College of Emergency Physicians NM Emergency Medicine Symposium. Apr 2, 2005. Albuquerque, NM.
15. Rotational Laxity Measurements Predict Outcome After ACL Reconstruction. T. Branch, J Browne, J. Campbell, C. Peer. Abstract Submitted. ISAKOS Congress 2007.
